Advertisement

Topics

Novo Nordisk-Aktie: Milliardenmarkt Diabetes - Aktienanalyse

10:04 EDT 4 May 2017 | FinanzNachrichten

Schwarzach am Main - Novo Nordisk-Aktie: Milliardenmarkt Diabetes - Aktienanalyse Die Aktie von Novo Nordisk (ISIN: DK0060534915, WKN: A1XA8R, Ticker-Symbol: NOVC, NASDAQ OTC Ticker-Symbol: NONOF) ...

Original Article: Novo Nordisk-Aktie: Milliardenmarkt Diabetes - Aktienanalyse

NEXT ARTICLE

More From BioPortfolio on "Novo Nordisk-Aktie: Milliardenmarkt Diabetes - Aktienanalyse"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...